All Stories

  1. Anti-EGFR anchored paclitaxel loaded PLGA nanoparticles for the treatment of triple negative breast cancer. In-vitro and in-vivo anticancer activities

    Article • PLoS ONE, November 2018, PLOS

    Subin Sankarankutty

  2. Updated Regulatory Considerations for Nanomedicines

    Article • Pharmaceutical Nanotechnology, January 2018, Bentham Science Publishers

    Subin Sankarankutty, JAYARAJAKUMAR KALAIMANI